Congressman Andy Harris just told you exactly what Schedule III rescheduling is: a 20-year stalling tactic designed to run out the clock on marijuana legalization. He said the quiet part out loud, and we should thank him for the honesty. This isn't about science. It isn't about safety. It isn't about protecting children or public health or any of the other rhetorical bullshit they've been feeding us for 87 years.

According to a study conducted by researchers at the University of Massachusetts at Amherst, together with Johns Hopkins University’s Bloomberg School of Public Health, public schools in Massachusetts saw a downward trend in marijuana-related disciplinary issues. After Massachusetts legalized recreational cannabis, consumption of the drug among teens dropped 25%, based on data from the Massachusetts Youth Risk Behavior Survey.

The New York Times wants you to believe America has a marijuana problem. I want you to believe the New York Times has an integrity problem. In February 2026, the editorial board of what's supposedly America's "paper of record" published a breathtaking reversal of their decade-old position on cannabis legalization. The headline might as well have been written by Kevin Sabet himself: essentially declaring that marijuana legalization was a "mistake" requiring "sober reassessment."

In another study, researchers in Germany found that orally administering THC was associated with improved survival times among terminally ill patients. Investigators analyzed the effects of cannabis-based medications and patient survival times among individuals registered in the Specialized Palliative Outpatient Care (SAPV) department.

A practical online head shop buyer’s guide covering quality, reviews, bongs, dab rigs, vaporizers, and what really matters when shopping for cannabis gear online.

Hemp and marijuana are the same plant. Scientifically, legally, botanically—it's all Cannabis sativa L. The only difference is an arbitrary legal threshold of 0.3% delta-9 THC content. Below that line? Legal hemp. Above it? Schedule I controlled substance, sitting right next to heroin.

There are serious, long-lasting implications for the US leaving the World Health Organization, including potential consequences for medical marijuana, the future of cannabis reform, and drug policy as a whole.

A recent study published in the journal Clinical Pharmacology and Therapeutics is challenging this long-held belief. Contrary to popular opinion, the research suggests that CBD may actually intensify the effects of THC, not dampen them. This revelation is sending ripples through the cannabis community and forcing us to reconsider our understanding of how these cannabinoids interact.

A recent study published in the International Journal of Drug Policy examined the drinking habits of cannabis beverage consumers and found something the alcohol industry has been dreading for years—people who consume THC-infused drinks report significant reductions in their alcohol consumption. We're not talking about a negligible dip. We're talking about people actively substituting a non-toxic, non-addictive substance (cannabis) for one of the most dangerous drugs legally available (alcohol).

A recent study published in the journal Cannabis and Cannabinoid Research has shed light on this phenomenon, suggesting that cannabis users had lower rates of severe Covid-19 infections and were less likely to face the worst outcomes of the virus.